Pharmaceutical Technology on MSN
J&J’s Caplyta wins MDD approval to extend revenue horizonThe US Food and Drug Administration (FDA) has approved Caplyta as an adjunctive therapy with antidepressants for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results